← Eichor
Study identifier: NCT07021859 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptide

Condition: Migraine Aura · Migraine With Aura  ·  Sponsor: Danish Headache Center

PhaseNA
Planned participants21
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

Calcitonin gene-related peptide (CGRP) is a key neuropeptide in migraine pathophysiology and treatment. This study investigates whether CGRP administration can trigger aura in individuals with a diagnosis of migraine with aura.

This description comes directly from the study's public registry record.

Talk to the study team

Haidar Al-Khazali, MD  ·  +4541598494  ·  haidardk@hotmail.com

Hakan Ashina, MD, PhD  ·  +4528102495  ·  haakan.ashina@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Rigshospitalet GlostrupGlostrup Municipality, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07021859